Provided by Tiger Trade Technology Pte. Ltd.

First Advantage Corp.

20.90
-0.3300-1.55%
Post-market: 20.900.00000.00%16:10 EDT
Volume:1.56M
Turnover:32.77M
Market Cap:3.59B
PE:143.92
High:21.36
Open:21.28
Low:20.74
Close:21.23
52wk High:25.15
52wk Low:8.82
Shares:171.54M
Float Shares:93.74M
Volume Ratio:0.76
T/O Rate:1.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1452
EPS(LYR):-0.2011
ROE:1.94%
ROA:2.82%
PB:2.77
PE(LYR):-103.95

Loading ...

First Advantage Shares Rise Ahead of Joining S&P Smallcap 600

Dow Jones
·
Jul 14

First Advantage (FA) Is Up 15.2% After Earnings Beat And S&P SmallCap 600 Inclusion – What’s Changed

Simply Wall St.
·
Jul 03

MetLife (MET) Launches NQA FA, Is The Stock Already Close To Fair Value?

Simply Wall St.
·
Jul 03

First Advantage (FA) Beats On Earnings And Joins S&P SmallCap 600, Is The Upside Priced In?

Simply Wall St.
·
Jul 02

German FA HQ raided by police in bribery probe days after shock World Cup exit

cityam
·
Jul 01

Larimar Therapeutics: Buy Rating on Nomlabofusp’s Robust FA Efficacy and De-Risked Regulatory Pathway

TIPRANKS
·
Jun 30

Larimar Therapeutics Reports Positive Open Label Data and Submission of First Module of Rolling BLA for Accelerated Approval of Nomlabofusp for Friedreich’s Ataxia

GlobeNewswire
·
Jun 29

Jonhon Optronic Technology Confirms Mass Production Capabilities for Key Fiber Optic Components

Deep News
·
Jun 25

Analysts Offer Insights on Industrial Goods Companies: First Advantage (FA) and GE Vernova Inc. (GEV)

TIPRANKS
·
Jun 23

State-Backed Funds Struggle for Access: Eight FA Contacts Still Yield No Entry into DeepSeek's Funding Round

Deep News
·
Jun 18

Investors Pay Hefty "Meeting Fee" Yet Fail to Secure Audience with DeepSeek's Founder

Deep News
·
Jun 18

Lexeo Therapeutics Announces Publication in JAMA Cardiology of Phase I/II Data for LX2006 in Friedreich Ataxia

GlobeNewswire
·
Jun 18

England, Kansas City and Taylor Swift: Why FA chose midwest as World Cup base

cityam
·
Jun 17

Lexeo finalizes SUNRISE-FA 2 pivotal trial protocol, statistical analysis plan

TIPRANKS
·
Jun 15

Lexeo Advances Pivotal LX2006 Trial for FA Cardiomyopathy

TIPRANKS
·
Jun 15

Lexeo Therapeutics Announces Regulatory Update and Registrational Trial Design for LX2006 Gene Therapy in Friedreich Ataxia

GlobeNewswire
·
Jun 15

First Advantage rises 7.3%

TIPRANKS
·
Jun 12

Shares of First Advantage Climb on Inclusion in S&P SmallCap 600 Index

Deep News
·
Jun 12

BUZZ-First Advantage jumps on S&P SmallCap addition

Reuters
·
Jun 12

First Advantage to replace Kennedy Wilson in S&P 600 at open on 6/16

TIPRANKS
·
Jun 12